EU agency recommends J&J's new tuberculosis drug

LONDON Fri Dec 20, 2013 7:15am EST

LONDON Dec 20 (Reuters) - European regulators said on Friday they had recommended approval Johnson & Johnson's new tuberculosis drug Sirturo, which was approved a year ago in the United States.

Recommendations for marketing approval by the European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) are normally endorsed by the European Commission within a couple of months.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.